Notably, the persistent and aberrant activation of Nrf2, which is a frequent occurrence in many tumors, provides cancer cells with a selective advantage, leading to tumor progression, metastasis, therapy resistance, and poor prognosis 14, 15. Here, NFE2L2 is linked to neoplasm.